Advertisement

Psychiatric Quarterly

, Volume 89, Issue 3, pp 645–665 | Cite as

A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD)

  • Simone Rehn
  • Guy D. Eslick
  • Vlasios Brakoulias
Review Article

Abstract

Randomised and sham-controlled trials (RCTs) of repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) have yielded conflicting results, which may be due to the variability in rTMS parameters used. We performed an updated systematic review and meta-analysis on the effectiveness of rTMS for the treatment of OCD and aimed to determine whether certain rTMS parameters, such as cortical target, may be associated with higher treatment effectiveness. After conducting a systematic literature review for RCTs on rTMS for OCD through to 1 December 2016 using MEDLINE, PubMed, Web of Science, PsycINFO, Google, and Google Scholar, we performed a random-effects meta-analysis with the outcome measure as pre-post changes in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores. To determine whether rTMS parameters may have influenced treatment effectiveness, studies were further analysed according to cortical target, stimulation frequency, and length of follow-up. Data were obtained from 18 RCTs on rTMS in the treatment of OCD. Overall, rTMS yielded a modest effect in reducing Y-BOCS scores with Hedge’s g of 0.79 (95% CI = 0.43–1.15, p < 0.001). Stimulation of the supplementary motor area yielded the greatest reductions in Y-BOCS scores relative to other cortical targets. Subgroup analyses suggested that low frequency rTMS was more effective than high frequency rTMS. The effectiveness of rTMS was also greater at 12 weeks follow-up than at four weeks follow-up. Our meta-analysis implies that low frequency rTMS applied over the supplementary motor area may offer the greatest effectiveness in the treatment of OCD. The therapeutic effects of rTMS also appear to persist post-treatment and may offer beneficial long-term effectiveness. With our findings, it is suggested that future large-scale studies focus on the supplementary motor area and include follow-up periods of 12 weeks or more.

Keywords

Repetitive transcranial magnetic stimulation rTMS Obsessive-compulsive disorder OCD Cortical target Stimulation frequency rTMS parameters Long-term effectiveness Treatment 

Notes

Acknowledgements

We would like to acknowledge the Sydney Medical School of the University of Sydney for funding a summer school placement for Simone Rehn to complete this research under the supervision of Dr. Vlasios Brakoulias.

Compliance with Ethical Standards

Conflict of Interests

The Authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Ruscio A, Stein D, Chiu W, Kessler R. The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication. Mol Psychiatry. 2010;15(1):53–63.CrossRefPubMedGoogle Scholar
  2. 2.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  3. 3.
    Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1999;56(2):121–7.CrossRefPubMedGoogle Scholar
  4. 4.
    DuPont RL, Rice D, Shiraki S, Rowland C. Economic costs of obsessive-compulsive disorder. Med Interface. 1995;8(4):102–9.PubMedGoogle Scholar
  5. 5.
    Fullana MA, Mataix-Cols D, Caspi A, Harrington H, Grisham JR, Moffitt TE, et al. Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatr. 2009;166(3):329–36.CrossRefPubMedGoogle Scholar
  6. 6.
    Stein DJ, Koen N, Fineberg N, Fontenelle LF, Matsunaga H, Osser D, et al. A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep. 2012;14(3):211–9.  https://doi.org/10.1007/s11920-012-0268-9.CrossRefPubMedGoogle Scholar
  7. 7.
    Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, et al. Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5(2):181–91.CrossRefPubMedGoogle Scholar
  8. 8.
    Abramowitz JS, Franklin ME, Foa EB. Empirical status of cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analytic review. Rom J Cogn Behav Psychother. 2002;2(2):89–104.Google Scholar
  9. 9.
    Rauch SL, Jenike MA. Management of treatment resistant obsessive-compulsive disorder: concepts and strategies. In: Hollander E, Zohar J, Marazziti D, Olivier B, editors. Obsessive compulsive disorder. Chicester: Wiley; 1994. p. 227–44.Google Scholar
  10. 10.
    Blom RM, Figee M, Vulink N, Denys D. Update on repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: different targets. Curr Psychiatry Rep. 2011;13(4):289–94.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Saba G, Moukheiber A, Pelissolo A. Transcranial cortical stimulation in the treatment of obsessive-compulsive disorders: efficacy studies. Curr Psychiatry Rep. 2015;17(5):1–8.CrossRefGoogle Scholar
  12. 12.
    Jaafari N, Rachid F, Rotge JY, Polosan M, El-Hage W, Belin D, et al. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry. 2012;13(3):164–77.CrossRefPubMedGoogle Scholar
  13. 13.
    Husain F, Nandipati G, Braun A, Cohen L, Tagamets M, Horwitz B. Simulating transcranial magnetic stimulation during PET with a large-scale neural network model of the prefrontal cortex and the visual system. NeuroImage. 2002;15(1):58–73.CrossRefPubMedGoogle Scholar
  14. 14.
    Pascual-Leone A, Keenan J, Freund S, Stinchfield Z, Tormos J, Parker A, et al. Repetitive transcranial magnetic stimulation trials in depression. Eur Neuropsychopharmacol. 1998;8:S123–S4.CrossRefGoogle Scholar
  15. 15.
    Speer AM, Kimbrell TA, Wassermann EM, Repella JD, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48(12):1133–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Fineberg N, Chamberlain S, Hollander E, Boulougouris V, Robbins T. Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment. Br J Pharmacol. 2011;164(4):1044–61.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16(1):43–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Del Casale A, Kotzalidis G, Rapinesi C, Serata D, Ambrosi E, Simonetti A, et al. Functional neuroimaging in obsessive-compulsive disorder. Neuropsychobiology. 2011;64(2):61–85.CrossRefPubMedGoogle Scholar
  19. 19.
    Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N, et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science. 2008;321(5887):421–2.CrossRefPubMedGoogle Scholar
  20. 20.
    Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry. 2005;57(8):901–10.  https://doi.org/10.1016/j.biopsych.2004.12.039.CrossRefPubMedGoogle Scholar
  21. 21.
    van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, et al. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry. 2005;62(3):301–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J, et al. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry. 2007;64(8):946–55.CrossRefPubMedGoogle Scholar
  23. 23.
    Nakao T, Nakagawa A, Nakatani E, Nabeyama M, Sanematsu H, Yoshiura T, et al. Working memory dysfunction in obsessive–compulsive disorder: a neuropsychological and functional MRI study. J Psychiatr Res. 2009;43(8):784–91.CrossRefPubMedGoogle Scholar
  24. 24.
    Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M, et al. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatr. 1997;154(6):867–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Sachdev PS, McBride R, Loo CK, Mitchell PB, Malhi GS, Croker VM. Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry. 2001;62(12):981–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Alonso P, Pujol J, Cardoner N, Benlloch L, Deus J, Menchon JM, et al. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2001;158(7):1143–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Sachdev PS, Loo CK, Mitchell PB, TF MF, Malhi GS. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation. Psychol Med. 2007;37(11):1645–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Berlim MT, Neufeld NH, Van den Eynde F. Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res. 2013;47(8):999–1006.  https://doi.org/10.1016/j.jpsychires.2013.03.022.CrossRefPubMedGoogle Scholar
  29. 29.
    Trevizol AP, Shiozawa P, Cook IA, Sato IA, Kaku CB, Guimaraes FB, et al. Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis. J ECT. 2016;32(4):262–6.  https://doi.org/10.1097/yct.0000000000000335.CrossRefPubMedGoogle Scholar
  30. 30.
    Gomes PO, Rosa MA, Allam N, de Souza ER, Brasil-Neto J. A randomized double-blind trial of repetitive transcranial magnetic stimulation in obsessive -compulsive disorder with three months follow-up. J ECT. 2012;28(2):149.Google Scholar
  31. 31.
    Hawken ER, Dilkov D, Kaludiev E, Simek S, Zhang F, Milev R. Transcranial magnetic stimulation of the supplementary motor area in the treatment of obsessive-compulsive disorder: a multi-site study. Int J Mol Sci. 2016;17(3):420.  https://doi.org/10.3390/ijms17030420.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Mantovani A, Simpson HB, Fallon BA, Rossi S, Lisanby SH. Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2010;13(2):217–27.CrossRefPubMedGoogle Scholar
  33. 33.
    Nauczyciel C, Le Jeune F, Naudet F, Douabin S, Esquevin A, Verin M, et al. Repetitive transcranial magnetic stimulation over the orbitofrontal cortex for obsessive-compulsive disorder: a double-blind, crossover study. Transcult Psychiatry. 2014;4:e436.CrossRefGoogle Scholar
  34. 34.
    Ruffini C, Locatelli M, Lucca A, Benedetti F, Insacco C, Smeraldi E. Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. Prim Care Companion J Clin Psychiatry. 2009;11(5):226–30.  https://doi.org/10.4088/PCC.08m00663.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Mantovani A, Rossi S, Bassi BD, Simpson HB, Fallon BA, Lisanby SH. Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome. Psychiatry Res. 2013;210(3):1026–32.CrossRefPubMedGoogle Scholar
  36. 36.
    Russo M, Naro A, Mastroeni C, Morgante F, Terranova C, Muscatello MR, et al. Obsessive-compulsive disorder: a "sensory-motor" problem? Int J Psychophysiol Off J Int Org Psychophysiol. 2014;92(2):74–8.  https://doi.org/10.1016/j.ijpsycho.2014.02.007. Google Scholar
  37. 37.
    Kumar N, Chadda RK. Augmentation effect of repetitive transcranial magnetic stimulation over the supplementary motor cortex in treatment refractory patients with obsessive compulsive disorder. Indian J Psychiatry. 2011;53(4):340–2.  https://doi.org/10.4103/0019-5545.91909.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Pelissolo A, Harika-Germaneau G, Rachid F, Gaudeau-Bosma C, Tanguy ML, BenAdhira R, et al. Repetitive transcranial magnetic stimulation to supplementary motor area in refractory obsessive-compulsive disorder treatment: a sham-controlled trial. Int J Neuropsychopharmacol. 2016;19(8)  https://doi.org/10.1093/ijnp/pyw025.
  39. 39.
    Berlim MT, Van den Eynde F, Daskalakis ZJ. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology. 2013;38(4):543–51.CrossRefPubMedGoogle Scholar
  40. 40.
    Prasko J, Paskova B, Zalesky R, Novak T, Kopecek M, Bares M, et al. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuroendocrinol Lett. 2006;27(3):327–32.PubMedGoogle Scholar
  41. 41.
    Kang JI, Kim CH, Namkoong K, Lee CI, Kim SJ. A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder. J Clin Psychiatry. 2009;70(12):1645–51.CrossRefPubMedGoogle Scholar
  42. 42.
    Badawy AA, El Sawy H, El Hay MA. Efficacy of repetitive transcranial magnetic stimulation in the management of obsessive compulsive disorder. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2010;47:393–7.Google Scholar
  43. 43.
    Sarkhel S, Sinha VK, Praharaj SK. Adjunctive high-frequency right prefrontal repetitive transcranial magnetic stimulation (rTMS) was not effective in obsessive-compulsive disorder but improved secondary depression. J Anxiety Disord. 2010;24(5):535–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Mansur CG, Myczkowki ML, Cabral SD, Sartorelli MDB, Bellini BB, Dias AM, et al. Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial. Int J Neuropsychopharmacol. 2011;14(10):1389–97.  https://doi.org/10.1017/s1461145711000575.CrossRefPubMedGoogle Scholar
  45. 45.
    Ma Z-R, Shi L-J. Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials. Int J Clin Exp Med. 2014;7(12):4897.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Zhang XZ, Gu Y, Zhao EQ, Li YZ. Research on treating refractory obsessive compulsive disorder with combination of sitaplam and repetitive transcranial magnetic stimulation. Chin J Health Psychol. 2010;18:778–80.Google Scholar
  47. 47.
    Cheng J, Li H, Shi YZ. The efficacy of repetitive transcranial magnetic stimulation on obsessive compulsive disorder. Journal of International Psychiatry. 2013;40:148–51.Google Scholar
  48. 48.
    Ma X, Huang Y, Liao L, Jin Y. A randomized double-blinded sham-controlled trial of alpha electroencephalogram-guided transcranial magnetic stimulation for obsessive-compulsive disorder. Chin Med J. 2014;127(4):601–6.PubMedGoogle Scholar
  49. 49.
    Haghighi M, Shayganfard M, Jahangard L, Ahmadpanah M, Bajoghli H, Pirdehghan A, et al. Repetitive transcranial magnetic stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD: results from a single-blind, randomized clinical trial with sham cross-over condition. J Psychiatr Res. 2015;68:238–44.CrossRefPubMedGoogle Scholar
  50. 50.
    Zhou D-D, Wang W, Wang G-M, Li D-Q, Kuang L. An updated meta-analysis: short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder. J Affect Disord. 2017;215:187–96.  https://doi.org/10.1016/j.jad.2017.03.033.CrossRefPubMedGoogle Scholar
  51. 51.
    Tang LY, Chu FC, Li YD, Xu ZP. Treating refractory obsessive compulsive disorder with combination of paroxetine and repetitive transcranial magnetic stimulation: a double-blind sham controlled study. Chinese Journal of Behavioral Medical and Brain Science. 2010;19(7):604–6.Google Scholar
  52. 52.
    Han CF, Jiang DF. Effect of slow frequency repetitive Transcranial Magnetic Stimulation (rTMS) combined with fluvoxamine on obsessivecompulsive disorder in maintenance stage. J Psychiatry. 2015;28:446–48.Google Scholar
  53. 53.
    Luo XF, Huang MI, Ye XJ. Controlled clinical study of sertraline alone or combined repetitive transcranial magnetic stimulation in patients with refractory obsessive-compulsive disorder. J Clin Psychiatry. 2015;25:238–240.Google Scholar
  54. 54.
    Elbeh KA, Elserogy YM, Khalifa HE, Ahmed MA, Hafez MH, Khedr EM. Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorders: double blind randomized clinical trial. Psychiatry Res. 2016;238:264–9.  https://doi.org/10.1016/j.psychres.2016.02.031.CrossRefPubMedGoogle Scholar
  55. 55.
    Jahangard L, Haghighi M, Shyayganfard M, Ahmadpanah M, Bahmani DS, Bajoghli H, et al. Repetitive transcranial magnetic stimulation improved symptoms of obsessive-compulsive disorder, but also cognitive performance: results from a randomized clinical trial with a cross-over design and sham condition. Neuropsychobiology. 2016;73(4):224–32.  https://doi.org/10.1159/000446287.CrossRefPubMedGoogle Scholar
  56. 56.
    Seo HJ, Jung YE, Lim HK, Um YH, Lee CU, Chae JH. Adjunctive low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex in patients with treatment-resistant obsessive-compulsive disorder: a randomized controlled trial. Clinical Psychopharmacology and Neuroscience. 2016;14(2):153–60.  https://doi.org/10.9758/cpn.2016.14.2.153.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Zhang ZM. A control study of sertraline plus rTMS in the treatment of refractory OCD. J Clin Psychosom Dis. 2016;22:41–3.Google Scholar
  58. 58.
    Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133(1):98–107.  https://doi.org/10.1016/j.pharmthera.2011.09.003.CrossRefPubMedGoogle Scholar
  59. 59.
    Moher D, Liberati A, Tetzlaff J, Altman DG. Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.Google Scholar
  61. 61.
    Organization WH. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization. 1993. Report No.: 9789241544559;9241544554; Contract No.: Report.Google Scholar
  62. 62.
    Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–11.CrossRefPubMedGoogle Scholar
  63. 63.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRefPubMedGoogle Scholar
  64. 64.
    Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses [journal article as teaching resource, deposited by John Flynn]. Br Med J. 2003;327:557–60.CrossRefGoogle Scholar
  65. 65.
    Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Orwin RG. A fail-safe N for effect size in meta-analysis. J Educ Stat. 1983;8(2):157–9.Google Scholar
  67. 67.
    Borenstein M, Hedges LV, Higgins J, Rothstein HR. Multiple comparisons within a study. Introduction to meta-analysis. Chichester: John Wiley & Sons, Ltd.; 2009. p. 239–42.CrossRefGoogle Scholar
  68. 68.
    de Wit SJ, de Vries FE, van der Werf YD, Cath DC, Heslenfeld DJ, Veltman EM, et al. Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder. Am J Psychiatr. 2012;169(10):1100–8.CrossRefPubMedGoogle Scholar
  69. 69.
    Oliveri M, Babiloni C, Filippi M, Caltagirone C, Babiloni F, Cicinelli P, et al. Influence of the supplementary motor area on primary motor cortex excitability during movements triggered by neutral or emotionally unpleasant visual cues. Exp Brain Res. 2003;149(2):214–21.CrossRefPubMedGoogle Scholar
  70. 70.
    Picard N, Strick PL. Imaging the premotor areas. Curr Opin Neurobiol. 2001;11(6):663–72.CrossRefPubMedGoogle Scholar
  71. 71.
    Rossi S, Bartalini S, Ulivelli M, Mantovani A, Di Muro A, Goracci A, et al. Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. Biol Psychiatry. 2005;57(1):16–20.CrossRefPubMedGoogle Scholar
  72. 72.
    van den Heuvel OA, Remijnse PL, Mataix-cols D, Vrenken H, Groenewegen HJ, HBM U, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain. 2009;132(Pt 4):853–68.PubMedGoogle Scholar
  73. 73.
    Kedzior KK, Azorina V, Reitz SK. More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997–2013. Neuropsychiatr Dis Treat. 2014;10:727–56.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Berlim M, Van den Eynde F, Tovar-Perdomo S, Daskalakis Z. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(02):225–39.CrossRefPubMedGoogle Scholar
  75. 75.
    Hegde A, Ravi M, Subhasini VS, Arumugham SS, Thirthalli J, Reddy YCJ. Repetitive transcranial magnetic stimulation over presupplementary motor area may not be helpful in treatment-refractory obsessive-compulsive disorder. A Case Series Journal of ECT. 2016;32(2):139–42.  https://doi.org/10.1097/yct.0000000000000291.PubMedGoogle Scholar
  76. 76.
    Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;254(3):156–64.CrossRefPubMedGoogle Scholar
  77. 77.
    Ridding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci. 2007;8(7):559–67.CrossRefPubMedGoogle Scholar
  78. 78.
    Stein DJ, Carey PD, Lochner C, Seedat S, Fineberg N, Andersen EW. Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy. CNS Spectr. 2008;13(6):492–8.CrossRefPubMedGoogle Scholar
  79. 79.
    Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran L, et al. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1997;12(6):309–16.CrossRefPubMedGoogle Scholar
  80. 80.
    Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48(8):730.CrossRefGoogle Scholar
  81. 81.
    Montgomery S, Kasper S, Stein D, Hedegaard KB, Lemming O. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2001;16(2):75–86.CrossRefPubMedGoogle Scholar
  82. 82.
    Tang W, Zhu Q, Gong X, Zhu C, Wang Y, Chen S. Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: a voxel-based morphometric and fMRI study of the whole brain. Behav Brain Res. 2016;313:17–22.  https://doi.org/10.1016/j.bbr.2016.07.004.CrossRefPubMedGoogle Scholar
  83. 83.
    Lefaucheur J-P, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150–206.CrossRefPubMedGoogle Scholar
  84. 84.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of PsychologyThe University of SydneySydneyAustralia
  2. 2.Department of PsychiatryNepean HospitalPenrith/SydneyAustralia
  3. 3.The Whiteley-Martin Research Centre, Discipline of SurgeryThe University of Sydney, Nepean HospitalSydney/PenrithAustralia
  4. 4.Sydney Medical School – Nepean, Discipline of PsychiatryThe University of SydneySydney/PenrithAustralia

Personalised recommendations